In the aftermath of the looting spree that ensued as a result of the protests across the country, the Independent Corrupt Practices and other Related Offences Commission (ICPC) is set to commence the investigation of the sources of looted items.
The commission said this is in response to increasing public demands on the Commission to investigate and uncover the rationale behind the storage of palliative materials meant for the suffering masses in warehouses across the country which were supposed to be distributed to the people.
It will be recall that some days ago SERAP sent a petition to the commission following reports of discovery of COVID-19 palliatives stored in warehouses in several states and carted away during the unrest across parts of the country
The commission disclosed in a statement released this morning that it had earlier in the year taken proactive measures to prevent corruption in the administration of the COVID-19 funds by setting up a monitoring team that was charged with the responsibility of preventing possible abuse.
It added that the Commission drew up “Guidelines for PTF Management of COVID-19 Relief Funds” and issued an advisory on the management of the COVID-19 relief funds, noting that the scope of the monitoring activities did not cover CACOVID funds which were donated by individuals and private sector organizations as palliatives, but only the Federal Government funds used to procure relief materials and other palliatives.
The commission has therefore assured that it will investigate the sources of goods looted from palliatives warehouses, the National Emergency Management Agency (NEMA) and private houses to unravel whether or not the properties looted were personally acquired, government procured, CACOVID donated, or are empowerment materials which are part of the constituency projects initiative of the Federal Government.
It further stated that the commission will also scale up the monitoring of Ministries, Departments and Agencies (MDAs) charged with the acquisition and distribution of COVID-19 palliative relief materials and make public its findings in due course.
